The global market for Pet Recombinant Vaccine is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Pet Recombinant Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Pet Recombinant Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Pet Recombinant Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Pet Recombinant Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Pet Recombinant Vaccine players cover Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva and Eli Lilly, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Pet Recombinant Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Pet Recombinant Vaccine market, with both quantitative and qualitative data, to help readers understand how the Pet Recombinant Vaccine market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Pet Recombinant Vaccine market and forecasts the market size by Type (Genetically Engineered Vaccines, Genetically Recombinant Vaccines and Transgenic Plant Vaccines), by Application (Dog, Cat, Dird and Others), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Genetically Engineered Vaccines
Genetically Recombinant Vaccines
Transgenic Plant Vaccines
DNA Vaccines
Segmentation by application
Dog
Cat
Dird
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska
Merck Animal Health
Merial (Sanofi)
Virbac
Zoetis (Pfizer)
Chapter Introduction
Chapter 1: Scope of Pet Recombinant Vaccine, Research Methodology, etc.
Chapter 2: Executive Summary, global Pet Recombinant Vaccine market size (sales and revenue) and CAGR, Pet Recombinant Vaccine market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Pet Recombinant Vaccine sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Pet Recombinant Vaccine sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Pet Recombinant Vaccine market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva, Eli Lilly, Heska, Merck Animal Health, Merial (Sanofi) and Virbac and etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pet Recombinant Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Pet Recombinant Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Pet Recombinant Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Pet Recombinant Vaccine Segment by Type
2.2.1 Genetically Engineered Vaccines
2.2.2 Genetically Recombinant Vaccines
2.2.3 Transgenic Plant Vaccines
2.2.4 DNA Vaccines
2.3 Pet Recombinant Vaccine Sales by Type
2.3.1 Global Pet Recombinant Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Pet Recombinant Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Pet Recombinant Vaccine Sale Price by Type (2017-2022)
2.4 Pet Recombinant Vaccine Segment by Application
2.4.1 Dog
2.4.2 Cat
2.4.3 Dird
2.4.4 Others
2.5 Pet Recombinant Vaccine Sales by Application
2.5.1 Global Pet Recombinant Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Pet Recombinant Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Pet Recombinant Vaccine Sale Price by Application (2017-2022)
3 Global Pet Recombinant Vaccine by Company
3.1 Global Pet Recombinant Vaccine Breakdown Data by Company
3.1.1 Global Pet Recombinant Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Pet Recombinant Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Pet Recombinant Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Pet Recombinant Vaccine Revenue by Company (2020-2022)
3.2.2 Global Pet Recombinant Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Pet Recombinant Vaccine Sale Price by Company
3.4 Key Manufacturers Pet Recombinant Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pet Recombinant Vaccine Product Location Distribution
3.4.2 Players Pet Recombinant Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pet Recombinant Vaccine by Geographic Region
4.1 World Historic Pet Recombinant Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Pet Recombinant Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Pet Recombinant Vaccine Annual Revenue by Geographic Region
4.2 World Historic Pet Recombinant Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Pet Recombinant Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Pet Recombinant Vaccine Annual Revenue by Country/Region
4.3 Americas Pet Recombinant Vaccine Sales Growth
4.4 APAC Pet Recombinant Vaccine Sales Growth
4.5 Europe Pet Recombinant Vaccine Sales Growth
4.6 Middle East & Africa Pet Recombinant Vaccine Sales Growth
5 Americas
5.1 Americas Pet Recombinant Vaccine Sales by Country
5.1.1 Americas Pet Recombinant Vaccine Sales by Country (2017-2022)
5.1.2 Americas Pet Recombinant Vaccine Revenue by Country (2017-2022)
5.2 Americas Pet Recombinant Vaccine Sales by Type
5.3 Americas Pet Recombinant Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet Recombinant Vaccine Sales by Region
6.1.1 APAC Pet Recombinant Vaccine Sales by Region (2017-2022)
6.1.2 APAC Pet Recombinant Vaccine Revenue by Region (2017-2022)
6.2 APAC Pet Recombinant Vaccine Sales by Type
6.3 APAC Pet Recombinant Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pet Recombinant Vaccine by Country
7.1.1 Europe Pet Recombinant Vaccine Sales by Country (2017-2022)
7.1.2 Europe Pet Recombinant Vaccine Revenue by Country (2017-2022)
7.2 Europe Pet Recombinant Vaccine Sales by Type
7.3 Europe Pet Recombinant Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pet Recombinant Vaccine by Country
8.1.1 Middle East & Africa Pet Recombinant Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Pet Recombinant Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Pet Recombinant Vaccine Sales by Type
8.3 Middle East & Africa Pet Recombinant Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pet Recombinant Vaccine
10.3 Manufacturing Process Analysis of Pet Recombinant Vaccine
10.4 Industry Chain Structure of Pet Recombinant Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pet Recombinant Vaccine Distributors
11.3 Pet Recombinant Vaccine Customer
12 World Forecast Review for Pet Recombinant Vaccine by Geographic Region
12.1 Global Pet Recombinant Vaccine Market Size Forecast by Region
12.1.1 Global Pet Recombinant Vaccine Forecast by Region (2023-2028)
12.1.2 Global Pet Recombinant Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pet Recombinant Vaccine Forecast by Type
12.7 Global Pet Recombinant Vaccine Forecast by Application
13 Key Players Analysis
13.1 Bayer Healthcare
13.1.1 Bayer Healthcare Company Information
13.1.2 Bayer Healthcare Pet Recombinant Vaccine Product Offered
13.1.3 Bayer Healthcare Pet Recombinant Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bayer Healthcare Main Business Overview
13.1.5 Bayer Healthcare Latest Developments
13.2 Vetoquinol S.A
13.2.1 Vetoquinol S.A Company Information
13.2.2 Vetoquinol S.A Pet Recombinant Vaccine Product Offered
13.2.3 Vetoquinol S.A Pet Recombinant Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Vetoquinol S.A Main Business Overview
13.2.5 Vetoquinol S.A Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Pet Recombinant Vaccine Product Offered
13.3.3 Boehringer Ingelheim Pet Recombinant Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Ceva
13.4.1 Ceva Company Information
13.4.2 Ceva Pet Recombinant Vaccine Product Offered
13.4.3 Ceva Pet Recombinant Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Ceva Main Business Overview
13.4.5 Ceva Latest Developments
13.5 Eli Lilly
13.5.1 Eli Lilly Company Information
13.5.2 Eli Lilly Pet Recombinant Vaccine Product Offered
13.5.3 Eli Lilly Pet Recombinant Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Eli Lilly Main Business Overview
13.5.5 Eli Lilly Latest Developments
13.6 Heska
13.6.1 Heska Company Information
13.6.2 Heska Pet Recombinant Vaccine Product Offered
13.6.3 Heska Pet Recombinant Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Heska Main Business Overview
13.6.5 Heska Latest Developments
13.7 Merck Animal Health
13.7.1 Merck Animal Health Company Information
13.7.2 Merck Animal Health Pet Recombinant Vaccine Product Offered
13.7.3 Merck Animal Health Pet Recombinant Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Merck Animal Health Main Business Overview
13.7.5 Merck Animal Health Latest Developments
13.8 Merial (Sanofi)
13.8.1 Merial (Sanofi) Company Information
13.8.2 Merial (Sanofi) Pet Recombinant Vaccine Product Offered
13.8.3 Merial (Sanofi) Pet Recombinant Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Merial (Sanofi) Main Business Overview
13.8.5 Merial (Sanofi) Latest Developments
13.9 Virbac
13.9.1 Virbac Company Information
13.9.2 Virbac Pet Recombinant Vaccine Product Offered
13.9.3 Virbac Pet Recombinant Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Virbac Main Business Overview
13.9.5 Virbac Latest Developments
13.10 Zoetis (Pfizer)
13.10.1 Zoetis (Pfizer) Company Information
13.10.2 Zoetis (Pfizer) Pet Recombinant Vaccine Product Offered
13.10.3 Zoetis (Pfizer) Pet Recombinant Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Zoetis (Pfizer) Main Business Overview
13.10.5 Zoetis (Pfizer) Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Pet Recombinant Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Pet Recombinant Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Genetically Engineered Vaccines
Table 4. Major Players of Genetically Recombinant Vaccines
Table 5. Major Players of Transgenic Plant Vaccines
Table 6. Major Players of DNA Vaccines
Table 7. Global Pet Recombinant Vaccine Sales by Type (2017-2022) & (K Units)
Table 8. Global Pet Recombinant Vaccine Sales Market Share by Type (2017-2022)
Table 9. Global Pet Recombinant Vaccine Revenue by Type (2017-2022) & ($ million)
Table 10. Global Pet Recombinant Vaccine Revenue Market Share by Type (2017-2022)
Table 11. Global Pet Recombinant Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Pet Recombinant Vaccine Sales by Application (2017-2022) & (K Units)
Table 13. Global Pet Recombinant Vaccine Sales Market Share by Application (2017-2022)
Table 14. Global Pet Recombinant Vaccine Revenue by Application (2017-2022)
Table 15. Global Pet Recombinant Vaccine Revenue Market Share by Application (2017-2022)
Table 16. Global Pet Recombinant Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Pet Recombinant Vaccine Sales by Company (2020-2022) & (K Units)
Table 18. Global Pet Recombinant Vaccine Sales Market Share by Company (2020-2022)
Table 19. Global Pet Recombinant Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Pet Recombinant Vaccine Revenue Market Share by Company (2020-2022)
Table 21. Global Pet Recombinant Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Pet Recombinant Vaccine Producing Area Distribution and Sales Area
Table 23. Players Pet Recombinant Vaccine Products Offered
Table 24. Pet Recombinant Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Pet Recombinant Vaccine Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Pet Recombinant Vaccine Sales Market Share Geographic Region (2017-2022)
Table 29. Global Pet Recombinant Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Pet Recombinant Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Pet Recombinant Vaccine Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Pet Recombinant Vaccine Sales Market Share by Country/Region (2017-2022)
Table 33. Global Pet Recombinant Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Pet Recombinant Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Pet Recombinant Vaccine Sales by Country (2017-2022) & (K Units)
Table 36. Americas Pet Recombinant Vaccine Sales Market Share by Country (2017-2022)
Table 37. Americas Pet Recombinant Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Pet Recombinant Vaccine Revenue Market Share by Country (2017-2022)
Table 39. Americas Pet Recombinant Vaccine Sales by Type (2017-2022) & (K Units)
Table 40. Americas Pet Recombinant Vaccine Sales Market Share by Type (2017-2022)
Table 41. Americas Pet Recombinant Vaccine Sales by Application (2017-2022) & (K Units)
Table 42. Americas Pet Recombinant Vaccine Sales Market Share by Application (2017-2022)
Table 43. APAC Pet Recombinant Vaccine Sales by Region (2017-2022) & (K Units)
Table 44. APAC Pet Recombinant Vaccine Sales Market Share by Region (2017-2022)
Table 45. APAC Pet Recombinant Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Pet Recombinant Vaccine Revenue Market Share by Region (2017-2022)
Table 47. APAC Pet Recombinant Vaccine Sales by Type (2017-2022) & (K Units)
Table 48. APAC Pet Recombinant Vaccine Sales Market Share by Type (2017-2022)
Table 49. APAC Pet Recombinant Vaccine Sales by Application (2017-2022) & (K Units)
Table 50. APAC Pet Recombinant Vaccine Sales Market Share by Application (2017-2022)
Table 51. Europe Pet Recombinant Vaccine Sales by Country (2017-2022) & (K Units)
Table 52. Europe Pet Recombinant Vaccine Sales Market Share by Country (2017-2022)
Table 53. Europe Pet Recombinant Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Pet Recombinant Vaccine Revenue Market Share by Country (2017-2022)
Table 55. Europe Pet Recombinant Vaccine Sales by Type (2017-2022) & (K Units)
Table 56. Europe Pet Recombinant Vaccine Sales Market Share by Type (2017-2022)
Table 57. Europe Pet Recombinant Vaccine Sales by Application (2017-2022) & (K Units)
Table 58. Europe Pet Recombinant Vaccine Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Pet Recombinant Vaccine Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Pet Recombinant Vaccine Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Pet Recombinant Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Pet Recombinant Vaccine Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Pet Recombinant Vaccine Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Pet Recombinant Vaccine Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Pet Recombinant Vaccine Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Pet Recombinant Vaccine Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Pet Recombinant Vaccine
Table 68. Key Market Challenges & Risks of Pet Recombinant Vaccine
Table 69. Key Industry Trends of Pet Recombinant Vaccine
Table 70. Pet Recombinant Vaccine Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Pet Recombinant Vaccine Distributors List
Table 73. Pet Recombinant Vaccine Customer List
Table 74. Global Pet Recombinant Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Pet Recombinant Vaccine Sales Market Forecast by Region
Table 76. Global Pet Recombinant Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Pet Recombinant Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Pet Recombinant Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Pet Recombinant Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Pet Recombinant Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Pet Recombinant Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Pet Recombinant Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Pet Recombinant Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Pet Recombinant Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Pet Recombinant Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Pet Recombinant Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Pet Recombinant Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Pet Recombinant Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Pet Recombinant Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Pet Recombinant Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Pet Recombinant Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Pet Recombinant Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Pet Recombinant Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 94. Bayer Healthcare Basic Information, Pet Recombinant Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. Bayer Healthcare Pet Recombinant Vaccine Product Offered
Table 96. Bayer Healthcare Pet Recombinant Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Bayer Healthcare Main Business
Table 98. Bayer Healthcare Latest Developments
Table 99. Vetoquinol S.A Basic Information, Pet Recombinant Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. Vetoquinol S.A Pet Recombinant Vaccine Product Offered
Table 101. Vetoquinol S.A Pet Recombinant Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. Vetoquinol S.A Main Business
Table 103. Vetoquinol S.A Latest Developments
Table 104. Boehringer Ingelheim Basic Information, Pet Recombinant Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 105. Boehringer Ingelheim Pet Recombinant Vaccine Product Offered
Table 106. Boehringer Ingelheim Pet Recombinant Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Boehringer Ingelheim Main Business
Table 108. Boehringer Ingelheim Latest Developments
Table 109. Ceva Basic Information, Pet Recombinant Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 110. Ceva Pet Recombinant Vaccine Product Offered
Table 111. Ceva Pet Recombinant Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Ceva Main Business
Table 113. Ceva Latest Developments
Table 114. Eli Lilly Basic Information, Pet Recombinant Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 115. Eli Lilly Pet Recombinant Vaccine Product Offered
Table 116. Eli Lilly Pet Recombinant Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. Eli Lilly Main Business
Table 118. Eli Lilly Latest Developments
Table 119. Heska Basic Information, Pet Recombinant Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 120. Heska Pet Recombinant Vaccine Product Offered
Table 121. Heska Pet Recombinant Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Heska Main Business
Table 123. Heska Latest Developments
Table 124. Merck Animal Health Basic Information, Pet Recombinant Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 125. Merck Animal Health Pet Recombinant Vaccine Product Offered
Table 126. Merck Animal Health Pet Recombinant Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. Merck Animal Health Main Business
Table 128. Merck Animal Health Latest Developments
Table 129. Merial (Sanofi) Basic Information, Pet Recombinant Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 130. Merial (Sanofi) Pet Recombinant Vaccine Product Offered
Table 131. Merial (Sanofi) Pet Recombinant Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. Merial (Sanofi) Main Business
Table 133. Merial (Sanofi) Latest Developments
Table 134. Virbac Basic Information, Pet Recombinant Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 135. Virbac Pet Recombinant Vaccine Product Offered
Table 136. Virbac Pet Recombinant Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. Virbac Main Business
Table 138. Virbac Latest Developments
Table 139. Zoetis (Pfizer) Basic Information, Pet Recombinant Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 140. Zoetis (Pfizer) Pet Recombinant Vaccine Product Offered
Table 141. Zoetis (Pfizer) Pet Recombinant Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 142. Zoetis (Pfizer) Main Business
Table 143. Zoetis (Pfizer) Latest Developments
List of Figures
Figure 1. Picture of Pet Recombinant Vaccine
Figure 2. Pet Recombinant Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pet Recombinant Vaccine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Pet Recombinant Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Pet Recombinant Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Genetically Engineered Vaccines
Figure 10. Product Picture of Genetically Recombinant Vaccines
Figure 11. Product Picture of Transgenic Plant Vaccines
Figure 12. Product Picture of DNA Vaccines
Figure 13. Global Pet Recombinant Vaccine Sales Market Share by Type in 2021
Figure 14. Global Pet Recombinant Vaccine Revenue Market Share by Type (2017-2022)
Figure 15. Pet Recombinant Vaccine Consumed in Dog
Figure 16. Global Pet Recombinant Vaccine Market: Dog (2017-2022) & (K Units)
Figure 17. Pet Recombinant Vaccine Consumed in Cat
Figure 18. Global Pet Recombinant Vaccine Market: Cat (2017-2022) & (K Units)
Figure 19. Pet Recombinant Vaccine Consumed in Dird
Figure 20. Global Pet Recombinant Vaccine Market: Dird (2017-2022) & (K Units)
Figure 21. Pet Recombinant Vaccine Consumed in Others
Figure 22. Global Pet Recombinant Vaccine Market: Others (2017-2022) & (K Units)
Figure 23. Global Pet Recombinant Vaccine Sales Market Share by Application (2017-2022)
Figure 24. Global Pet Recombinant Vaccine Revenue Market Share by Application in 2021
Figure 25. Pet Recombinant Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Pet Recombinant Vaccine Revenue Market Share by Company in 2021
Figure 27. Global Pet Recombinant Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Pet Recombinant Vaccine Revenue Market Share by Geographic Region in 2021
Figure 29. Global Pet Recombinant Vaccine Sales Market Share by Region (2017-2022)
Figure 30. Global Pet Recombinant Vaccine Revenue Market Share by Country/Region in 2021
Figure 31. Americas Pet Recombinant Vaccine Sales 2017-2022 (K Units)
Figure 32. Americas Pet Recombinant Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. APAC Pet Recombinant Vaccine Sales 2017-2022 (K Units)
Figure 34. APAC Pet Recombinant Vaccine Revenue 2017-2022 ($ Millions)
Figure 35. Europe Pet Recombinant Vaccine Sales 2017-2022 (K Units)
Figure 36. Europe Pet Recombinant Vaccine Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Pet Recombinant Vaccine Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa Pet Recombinant Vaccine Revenue 2017-2022 ($ Millions)
Figure 39. Americas Pet Recombinant Vaccine Sales Market Share by Country in 2021
Figure 40. Americas Pet Recombinant Vaccine Revenue Market Share by Country in 2021
Figure 41. United States Pet Recombinant Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Pet Recombinant Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Pet Recombinant Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Pet Recombinant Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Pet Recombinant Vaccine Sales Market Share by Region in 2021
Figure 46. APAC Pet Recombinant Vaccine Revenue Market Share by Regions in 2021
Figure 47. China Pet Recombinant Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Pet Recombinant Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Pet Recombinant Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Pet Recombinant Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Pet Recombinant Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Pet Recombinant Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Pet Recombinant Vaccine Sales Market Share by Country in 2021
Figure 54. Europe Pet Recombinant Vaccine Revenue Market Share by Country in 2021
Figure 55. Germany Pet Recombinant Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Pet Recombinant Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Pet Recombinant Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Pet Recombinant Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Pet Recombinant Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Pet Recombinant Vaccine Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Pet Recombinant Vaccine Revenue Market Share by Country in 2021
Figure 62. Egypt Pet Recombinant Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Pet Recombinant Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Pet Recombinant Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Pet Recombinant Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Pet Recombinant Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Pet Recombinant Vaccine in 2021
Figure 68. Manufacturing Process Analysis of Pet Recombinant Vaccine
Figure 69. Industry Chain Structure of Pet Recombinant Vaccine
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)